Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and its Relationship with End‐Organ Damage Among Adults With Arterial Hypertension
The Journal of Clinical Hypertension · 2025
DOI: 10.1111/jch.70106 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Clinical Hypertension, 2025. Verfasst von Silvia Palomo-Piñón und 12 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Expertos en Hipertensión Arterial México (GREHTA), Ciudad de México, Mexico. Hauptthemen laut MEDLINE: Hypertension, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Arterial hypertension often coexists with comorbidities that increase vascular damage. Although the primary goal is to reduce cardiovascular risk, the available risk scores can produce varying estimates. Here, we aim to compare the prevalence of cardiovascular risk categories using three equations (Globorisk, SCORE2, and PREVENT) in adults living with arterial hypertension and to assess their association as stratification tools for end‐organ damage (EOD). To achieve this, we performed a cross‐sectional sub‐analysis of the RIHTA study, an electronic health record‐based registry of adults with arterial hypertension in Mexican primary care centers. EOD was defined as aortic stiffness, reduced eGFR, hypertensive retinopathy, peripheral artery disease, or left ventricular hypertrophy. Inverse probability weighting (IPW) was used to evaluate the association between cardiovascular risk and EOD, adjusting for relevant confounders, and areas under the receiver operator curve (AUROC) were calculated to assess detection capacity. Among 4512 participants (median age 64 years; 61% women), EOD was present in 33% ( n = 1492). The PREVENT equation yielded the highest median 10‐year risk (15%, IQR 8–24), followed by Globorisk laboratory‐based (12%, 7–22), Globorisk office‐based (11%, 7–19), and SCORE2 (5.06%, 3.86–7.18). In IPW models, each 1% increase in score was associated with higher odds of EOD (PREVENT OR 1.16, 95% CI 1.15–1.17; Globorisk‐office 1.09, 1.08–1.10; Globorisk‐lab 1.07, 1.06–1.08; SCORE2 1.04, 1.02–1.06). The PREVENT score demonstrated the strongest discrimination for detecting EOD (AUROC: 0.751, 0.735–0.750). These findings suggest that among adults with arterial hypertension, the PREVENT score identifies high‐risk individuals and improves discrimination for EOD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grupo de Expertos en Hipertensión Arterial México (GREHTA), Ciudad de México, Mexico.
- Grupo Colaborativo en Hipertensión Arterial (GCHTA), Ciudad de México, Mexico.
- Hospital Ángeles del Pedregal, Ciudad de México, Mexico.
- Hospital Puerta de Hierro Andares, Zapopan, Jalisco, Mexico.
- Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.
- Unidad Médica de Alta Especialidad de Cardiología, Centro Médico Nacional SXXI, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.
ORCID-Profile: Silvia Palomo-Piñón, Luis Alcocer, Humberto Álvarez-López, Ernesto G Cardona-Muñoz, Adolfo Chávez-Mendoza, Enrique Díaz-Díaz, Héctor Galván-Oseguera, Martin Rosas-Peralta, Luis Rey García-Cortés, Moisés Moreno-Noguez, Neftali Eduardo Antonio-Villa
Zitieren
APA
Palomo-Piñón, S., Alcocer, L., Álvarez-López, H., Cardona-Muñoz, E. G., Chávez-Mendoza, A., Díaz-Díaz, E., Enciso-Muñoz, J. M., Galván-Oseguera, H., Rosas-Peralta, M., García-Cortés, L. R., Moreno-Noguez, M., Antonio-Villa, N. E., & Mexican Group of Experts on Arterial Hypertension (2025). Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and its Relationship with End‐Organ Damage Among Adults With Arterial Hypertension. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.70106
Vancouver
Palomo-Piñón S, Alcocer L, Álvarez-López H, Cardona-Muñoz EG, Chávez-Mendoza A, Díaz-Díaz E, et al. Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and its Relationship with End‐Organ Damage Among Adults With Arterial Hypertension. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.70106
BibTeX
@article{PalomoPin2025,
author = {Palomo-Piñón, Silvia and Alcocer, Luis and Álvarez-López, Humberto and Cardona-Muñoz, Ernesto G and Chávez-Mendoza, Adolfo and Díaz-Díaz, Enrique and Enciso-Muñoz, José Manuel and Galván-Oseguera, Héctor and Rosas-Peralta, Martin and García-Cortés, Luis Rey and Moreno-Noguez, Moisés and Antonio-Villa, Neftali Eduardo and Mexican Group of Experts on Arterial Hypertension, Mexican Group of Experts on Arterial Hypertension},
title = {Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and its Relationship with End‐Organ Damage Among Adults With Arterial Hypertension},
journal = {The Journal of Clinical Hypertension},
year = {2025},
doi = {10.1111/jch.70106}
}
EUVIMED